Director. Pharmacokinetics Sciences Governance
Novartis
Cambridge , Massachusetts
Mohsen Rajabi is the Scientific Director in the Translational Medicine, Pharmacokinetic Sciences Group at Novartis. Before joining Novartis, Mohsen worked at the FDA for 14 years where he provided scientific expertise on clinical pharmacology and immunogenicity issues related to biosimilar and therapeutic biologics. He led collaborative initiatives to develop and establish clinical pharmacology and immunogenicity guidance and policies. Mohsen also conducted inspection of bioanalytical and clinical studies in support of regulatory submissions. Mohsen received his Ph.D. in Peptide Chemistry from the Department of Chemistry and Biochemistry, University of Maryland. He researched the role of defensins in innate and adaptive immune responses to microbial infection. This work was the basis of several publication about the multifaceted biological activity of defensins.
Disclosure information not submitted.
Evaluating the Immunogenicity of Peptides form the Clinical Pharmacology Perspective
Tuesday, July 15, 2025
8:05 AM - 8:35 AM ET
Beyond the Analysis: Immunogenicity and Beyond: Panel Discussion
Tuesday, July 15, 2025
11:05 AM - 11:55 AM ET